Through the investigation of mouse models with biliary tract cancer driven by TP53 loss, the reprogramming of hepatocytes to cholangiocytes was strengthened to facilitate the formation of hepatocyte-derived ICCA. This evidence concerns the gene TP53 and biliary tract cancer.